Jonathan Caron
Impact in
-
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Phagocytosis and Immune Regulation
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 3
- Immune cells in cancer 3
-
- Extracellular vesicles in disease 2
- Renal and related cancers 1
- Co-authors
- Mark Bodman‐Smith (3 shared papers)Tamara Muliaditan (3 shared papers)James W. Opzoomer (3 shared papers)James N. Arnold (3 shared papers)Peter M. Gordon (2 shared papers)Tony Ng (2 shared papers)Sharanpreet Lall (2 shared papers)Cheryl Gillett (2 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Clinical Cancer Research (1 paper)Immunology (1 paper)American Journal of Hematology (1 paper)Nature Communications (1 paper)
- Partner nations
- FranceUnited KingdomChina
In The Last Decade
Jonathan Caron
16 papers receiving 315 citations
Peers
Comparison fields: 5 of 58
- Immunology 176
- Oncology 106
- Equine 6
- Genetics 38
- Cancer Research 30
Countries citing papers authored by Jonathan Caron
This map shows the geographic impact of Jonathan Caron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Caron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Caron more than expected).
Fields of papers citing papers by Jonathan Caron
This network shows the impact of papers produced by Jonathan Caron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Caron. The network helps show where Jonathan Caron may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Caron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 90 | |
| 2 | 2021 | 56 | |
| 3 | 2018 | 50 | |
| 4 | 2021 | 29 | |
| 5 | 2021 | 24 | |
| 6 | 2011 | 15 | |
| 7 | Equine testicular neoplasia | 1985 | 12 |
| 8 | 2020 | 9 | |
| 9 | 2024 | 8 | |
| 10 | 2016 | 7 | |
| 11 | 2023 | 5 | |
| 12 | 2022 | 5 | |
| 13 | 2023 | 2 | |
| 14 | 2006 | 2 | |
| 15 | [Radiculography with Dimer X. 1st results after 630 examinations]. | 1970 | 2 |
| 16 | [Leiomyoma of the esophagus]. | 1972 | 1 |
About Jonathan Caron
Jonathan Caron is a scholar working on Immunology, Molecular Biology, Surgery, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 317 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (3 papers), Immune cells in cancer (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Extracellular vesicles in disease (2 papers), Nanoplatforms for cancer theranostics (1 paper) and Renal and related cancers (1 paper). The work is most often cited by research in Immunology (176 citations), Oncology (106 citations), Equine (6 citations), Genetics (38 citations) and Cancer Research (30 citations). Jonathan Caron has collaborated with scholars based in France, United Kingdom and China. Frequent co-authors include Mark Bodman‐Smith, Tamara Muliaditan, James W. Opzoomer, James N. Arnold, Peter M. Gordon, Tony Ng, Sharanpreet Lall, Cheryl Gillett, Paris Kosti and Sandra S. Diebold. Their work appears in journals such as Frontiers in Immunology, Clinical Cancer Research, Immunology, American Journal of Hematology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.